• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Endosonics breaks ground at new site

Article

Intravascular ultrasound developer Endosonics broke ground thisweek on a new manufacturing facility in Rancho Cordova, CA. ThePleasanton, CA, vendor said that strong demand for its productsnecessitated the construction of the 44,000-square-foot

Intravascular ultrasound developer Endosonics broke ground thisweek on a new manufacturing facility in Rancho Cordova, CA. ThePleasanton, CA, vendor said that strong demand for its productsnecessitated the construction of the 44,000-square-foot facility,which will manufacture the company's Oracle and Five-64 catheters.Endosonics will continue to produce its current line of cathetersin Pleasanton.

In other news, Endosonics reported last month that its CardioVascularDynamics (CVD) subsidiary has signed an agreement with the vascularintervention group of Guidant to develop new perfusion angioplastycatheters. Guidant last year received an option for CVD's mechanicalangioplasty catheter (MAC) technology, and last month's agreementexercises that option.

As part of the deal, Guidant granted CVD exclusive rights tomarket Guidant's SmartNeedle products, which use Doppler ultrasound-guidedneedle technology to locate and access arteries and veins in patients.

Recent Videos
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, Part 1
Addressing Cybersecurity Issues in Radiology
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.